{"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"281"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"784"}],"units":"Participants"}],"groups":[{"description":"Participants received three placebo tablets administered orally every day (QD).","id":"BG000","title":"Placebo Phase 2"},{"description":"Participants received one 1 mg Baricitinib tablet administered orally QD, and two placebo tablets administered orally QD to maintain the blind.","id":"BG001","title":"1 mg Baricitinib Phase 2"},{"description":"Participants received one 2 mg Baricitinib tablet administered orally QD, and two placebo tablets administered orally QD to maintain the blind.","id":"BG002","title":"2 mg Baricitinib Phase 2"},{"description":"Participants received one 4 mg Baricitinib tablet administered orally, QD and two placebo tablet administered orally QD to maintain the blind.","id":"BG003","title":"4 mg Baricitinib Phase 2"},{"description":"Participants received two placebo tablets administered orally QD.","id":"BG004","title":"Placebo Phase 3"},{"description":"Participants received one 2 mg Baricitinib tablet administered orally QD, and one placebo tablet administered orally QD to maintain the blind.","id":"BG005","title":"2 mg Baricitinib Phase 3"},{"description":"Participants received one 4 mg Baricitinib tablet administered orally, QD and one placebo tablet QD administered orally to maintain the blind.","id":"BG006","title":"4 mg Baricitinib Phase 3"},{"description":"Participants who received one 4 mg Baricitinib tablet administered orally QD.","id":"BG007","title":"4 mg Baricitinib Phase 3 Open-Label Addendum"},{"description":"Total of all reporting groups","id":"BG008","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"14.23","value":"40.5"},{"groupId":"BG001","spread":"11.26","value":"38.6"},{"groupId":"BG002","spread":"13.75","value":"42.5"},{"groupId":"BG003","spread":"14.91","value":"42.4"},{"groupId":"BG004","spread":"12.91","value":"37.4"},{"groupId":"BG005","spread":"12.78","value":"38.0"},{"groupId":"BG006","spread":"13.27","value":"36.3"},{"groupId":"BG007","spread":"8.75","value":"46.0"},{"groupId":"BG008","spread":"13.0","value":"37.8"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"280"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"783"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"The number analyzed includes only participants with observed (non-missing) data for each specific baseline characteristic. In the \"4 mg Baricitinib Phase 3\" arm, age data for one participant was not collected and therefore couldn't be reported (n=280).","title":"Age, Continuous","unitOfMeasure":"years"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"23"},{"groupId":"BG003","value":"25"},{"groupId":"BG004","value":"109"},{"groupId":"BG005","value":"109"},{"groupId":"BG006","value":"165"},{"groupId":"BG007","value":"15"},{"groupId":"BG008","value":"480"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"2"},{"groupId":"BG004","value":"80"},{"groupId":"BG005","value":"75"},{"groupId":"BG006","value":"116"},{"groupId":"BG007","value":"5"},{"groupId":"BG008","value":"304"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"281"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"784"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"8"},{"groupId":"BG005","value":"5"},{"groupId":"BG006","value":"8"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"22"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"4"},{"groupId":"BG004","value":"78"},{"groupId":"BG005","value":"76"},{"groupId":"BG006","value":"114"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"282"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"3"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"17"},{"groupId":"BG005","value":"7"},{"groupId":"BG006","value":"28"},{"groupId":"BG007","value":"19"},{"groupId":"BG008","value":"83"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"20"},{"groupId":"BG003","value":"19"},{"groupId":"BG004","value":"83"},{"groupId":"BG005","value":"93"},{"groupId":"BG006","value":"123"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"381"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"6"},{"groupId":"BG007","value":"1"},{"groupId":"BG008","value":"9"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"1"},{"groupId":"BG006","value":"1"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"4"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"281"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"784"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"70"},{"groupId":"BG005","value":"70"},{"groupId":"BG006","value":"107"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"247"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"281"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"784"}],"units":"Participants"}],"title":"South Korea"},{"categories":[{"measurements":[{"groupId":"BG000","value":"25"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"24"},{"groupId":"BG003","value":"24"},{"groupId":"BG004","value":"103"},{"groupId":"BG005","value":"102"},{"groupId":"BG006","value":"153"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"476"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"281"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"784"}],"units":"Participants"}],"title":"United States"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"12"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"281"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"784"}],"units":"Participants"}],"title":"Japan"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"16"},{"groupId":"BG005","value":"12"},{"groupId":"BG006","value":"21"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"49"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"281"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"784"}],"units":"Participants"}],"title":"Mexico"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Region of Enrollment","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"15.69","value":"90.0"},{"groupId":"BG001","spread":"17.65","value":"89.3"},{"groupId":"BG002","spread":"19.32","value":"86.1"},{"groupId":"BG003","spread":"17.52","value":"83.4"},{"groupId":"BG004","spread":"17.82","value":"84.7"},{"groupId":"BG005","spread":"18.01","value":"86.8"},{"groupId":"BG006","spread":"18.18","value":"85.3"},{"groupId":"BG007","spread":"21.28","value":"79.1"},{"groupId":"BG008","spread":"17.5","value":"85.6"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"28"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"27"},{"groupId":"BG004","value":"189"},{"groupId":"BG005","value":"184"},{"groupId":"BG006","value":"281"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"784"}],"units":"Participants"}]}],"description":"SALT uses a visual aid showing the division of the scalp hair into 4 areas - top of the head constituting 40% of total surface, the posterior/back of head 24%, right and left side of head 18% each. The percentage of hair loss in each area is determined and is multiplied by the percentage of scalp covered by that area. The total sum of the 4 products of each area will give the SALT score. Only terminal hair is included in the SALT; vellus hair or any fine downy hair is not taken into account for scoring. The score will range from 0% to 100%, with lower score indicating better health outcomes.","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Baseline Disease Severity of Alopecia Tool (SALT) Score","unitOfMeasure":"units on a scale"}],"populationDescription":"All randomized participants from Phase 2, Phase 3, and the Phase 3 open-label addendum."}